| # | Drug | Count |
|---|---|---|
| 0 | ISOTRETINOIN | 14 |
| 1 | FUROSEMIDE | 11 |
| 2 | ALPRAZOLAM | 8 |
| 3 | VENLAFAXINE HYDROCHLORIDE | 7 |
| 4 | BUPROPION HYDROCHLORIDE | 6 |
| 5 | ARIPIPRAZOLE | 5 |
| 6 | CLOZAPINE | 5 |
| 7 | ADALIMUMAB | 4 |
| 8 | METOPROLOL | 4 |
| 9 | METOPROLOL TARTRATE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR | 3 | 0.0038 |
| 1 | CLASCOTERONE | 2 | 0.0014 |
| 2 | DISULFIRAM | 1 | 0.0009 |
| 3 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| 4 | UREA | 1 | 0.0005 |
| 5 | DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE | 1 | 0.0003 |
| 6 | ISOTRETINOIN | 14 | 0.0003 |
| 7 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 3 | 0.0002 |
| 8 | GLATIRAMER ACETATE INJECTION | 1 | 0.0002 |
| 9 | FLUOXETINE HCL | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 1 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 3 | 0.0002 |
| 2 | Sulfone [EPC] | 1 | 0.0001 |
| 3 | Barbiturate [EPC] | 1 | 0.0001 |
| 4 | Retinoid [EPC] | 17 | 0.0001 |
| 5 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 6 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 7 | Androgen Receptor Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Androgen [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Analog Antiviral [EPC] | 3 | 0.0000 |